miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer

International Journal of Oncology

Volumn 39, Issue 2, 2011, Pages 311-318

  Akçakaya, Pinar ^a   Ekelund, Susanne ^b   Kolosenko, Iryna ^a   Caramuta, Stefano ^a   Özata, Denizm ^a   Xie, Hong ^a   Lindforss, Ulrik ^b   Olivecrona, Hans ^b   Lui, Weng Onn ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

Colorectal cancer; Meta stasis; miRNA; Prognosis; Survival

Indexed keywords

MICRORNA; MIR 133B; MIR 185; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; COHORT ANALYSIS; COLORECTAL CANCER; FEMALE; HUMAN; MALE; METASTASIS; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; CLUSTER ANALYSIS; COLORECTAL NEOPLASMS; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS;

EID: 79959919757     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1043     Document Type: Article

References (44)

1. Jemal A, Bray F, Center MM, Ferlay J Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005
3. Cunningham D, Atkin W, Lenz HJ Lynch HT, Minsky B, Nordlinger B and Starling N: Colorectal cancer. Lancet 375: 1030-1047, 2010.
4. Bandres E, Agirre X, Ramirez N, Zarate R and Garcia-Foncillas J MicroRNAs as cancer players: potential clinical and biological effects. DNA Cell Biol 26: 273-282, 2007
5. Volinia S, Calin GA, Liu CG, et al: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261, 2006. (Pubitemid 43271657)
6. Nelson PT, Baldwin DA, Scearce LM, Oberholtzer JC, Tobias JW and Mourelatos Z: Microarray-based, high-throughput gene expression profiling of microRNAs. Nat Methods 1: 155-161, 2004
7. Lu J Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005 (Pubitemid 40839735)
8. Kim VN, Han J and Siomi MC: Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10: 126-139, 2009
9. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004
10. Doench JG and Sharp PA: Specificity of microRNA target selection in translational repression. Genes Dev 18: 504-511, 2004 (Pubitemid 38372808)
11. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004
12. Michael MZ, O'Connor SM, van Holst Pellekaan NG, Young GP and James RJ: Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1: 882-891, 2003. (Pubitemid 37288707)
13. Chan JA, Krichevsky AM and Kosik KS: MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65: 6029-6033, 2005 (Pubitemid 40994386)
14. Hayashita Y, Osada H, Tatematsu Y, et al: A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65: 9628-9632, 2005. (Pubitemid 41541436)
15. He H, Jazdzewski K, Li W, et al: The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 102: 19075-19080, 2005 (Pubitemid 43049568)
16. Iorio MV, Ferracin M, Liu CG, et al: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070, 2005 (Pubitemid 41161233)
17. Bandres E, Cubedo E, Agirre X, et al: Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 5: 29, 2006.
18. Hossain A, Kuo MT and Saunders GF: Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol Cell Biol 26: 8191-8201, 2006. (Pubitemid 44631015)
19. Roldo C, Missiaglia E, Hagan JP, et al: MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 24: 4677-4684, 2006. (Pubitemid 46630931)
20. Yanaihara N, Caplen N, Bowman E, et al: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198, 2006. (Pubitemid 43357945)
21. Motoyama K, Inoue H, Takatsuno Y, et al: Over- and underexpressed microRNAs in human colorectal cancer. Int J Oncol 34: 1069-1075, 2009
22. Chen X, Guo X, Zhang H, et al: Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 28: 1385-1392, 2009
23. Gregersen LH, Jacobsen AB, Frankel LB, Wen J Krogh A and Lund AH: MicroRNA-145 targets YES and STAT1 in colon cancer cells. PLoS ONE 5: e8836, 2010.
24. Schetter AJ Leung SY, Sohn JJ et al: MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299: 425-436, 2008. (Pubitemid 351185951)
25. Lanza G, Ferracin M, Gafa R, et al: mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol Cancer 6: 54, 2007
26. Schepeler T, Reinert JT, Ostenfeld MS, et al: Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 68: 6416-6424, 2008.
27. Lindforss U, Fredholm H, Papadogiannakis N, Gad A, Zetterquist H and Olivecrona H: Allelic loss is heterogeneous throughout the tumor in colorectal carcinoma. Cancer 88: 2661-2667, 2000. (Pubitemid 30417925)
28. De Hoon MJ, Imoto S, Nolan J and Miyano S: Open source clustering software. Bioinformatics 20: 1453-1454, 2004 (Pubitemid 38931415)
29. Saldanha AJ: Java Treeview-extensible visualization of microarray data. Bioinformatics 20: 3246-3248, 2004.
30. Tusher VG, Tibshirani R and Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121, 2001. (Pubitemid 32397092)
31. Liu H, Brannon AR, Reddy AR, et al: Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell renal cell carcinoma. BMC Syst Biol 4: 51, 2010.
32. Abaan OD and Toretsky JA: PTPL1: a large phosphatase with a split personality. Cancer Metastasis Rev 27: 205-214, 2008.
33. Wang Z, Shen D, Parsons DW, et al: Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science 304: 1164-1166, 2004 (Pubitemid 38661854)
34. Takahashi Y, Forrest AR, Maeno E, Hashimoto T, Daub CO and Yasuda J: MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines. PLoS One 4: e6677, 2009
35. Imam JS, Buddavarapu K, Lee-Chang JS, Ganapathy S, Camosy C, Chen Y and Rao MK: MicroRNA-185 suppresses tumor growth and progression by targeting the Sixl oncogene in human cancers. Oncogene 29: 4971-4979, 2010.
36. Crawford M, Batte K, Yu L, et al: MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. Biochem Biophys Res Commun 388: 483-489, 2009
37. Ichimi T, Enokida H, Okuno Y, et al: Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int J Cancer 125: 345-352, 2009
38. Guo J Miao Y, Xiao B, Huan R Jiang Z, Meng D and Wang Y: Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol 24: 652-657, 2009
39. Kano M, Seki N, Kikkawa N, et al: miR-145, miR-133a and miR-133b: Tumor suppressive miRNAs target FSCNl in esophageal squamous cell carcinoma. Int J Cancer 127: 2804-2814, 2010.
40. Wong TS, Ho WK, Chan JY, Ng RW and Wei WI: Mature miR-184 and squamous cell carcinoma of the tongue. Sci World J 9: 130-132, 2009
41. Dyrskjot L, Ostenfeld MS, Bramsen JB, et al: Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res 69: 4851-4860, 2009
42. Hu G, Chen D, Li X, Yang K, Wang H and Wu W: miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo. Cancer Biol Ther 10: 190-197, 2010.
43. NielsenBS, Jorgensen S, Fog JU, et al: Highlevels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin Exp Metastasis 28: 27-38, 2011.
44. Mitchell PS, Parkin RK, Kroh EM, et al: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105: 10513-10518, 2008.